...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Design, synthesis, and evaluation of 2-aryl-7-(3',4'-dialkoxyphenyl)-pyrazolo(1,5-a)pyrimidines as novel PDE-4 inhibitors.
【24h】

Design, synthesis, and evaluation of 2-aryl-7-(3',4'-dialkoxyphenyl)-pyrazolo(1,5-a)pyrimidines as novel PDE-4 inhibitors.

机译:设计,合成和评估2-芳基-7-(3',4'-二烷氧基苯基)-吡唑并(1,5-a)嘧啶作为新型PDE-4抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Described herein is design, synthesis, and biological evaluation of novel series of 2-aryl-7-(3',4'-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines acting as inhibitors of type 4 phosphodiesterase (PDE4) which is known as a good target for the treatment of asthma and COPD. For this purpose, structure optimization was conducted with the aid of structure-based drug design using the known X-ray crystallography. Also, biological effects of these compounds on the target enzyme were evaluated by using in vitro assays, leading to the potent and selective PDE-4 inhibitor (IC(50)<10nM).
机译:本文描述了新颖的2-芳基-7-(3',4'-二烷氧基苯基)-吡唑并[1,5-a]嘧啶系列的新颖系列的设计,合成和生物学评估,该抑制剂可作为4型磷酸二酯酶(PDE4)的抑制剂被认为是治疗哮喘和COPD的好靶标。为此目的,使用已知的X射线晶体学,借助于基于结构的药物设计进行结构优化。此外,通过使用体外测定法评估了这些化合物对目标酶的生物学作用,从而产生了有效且选择性的PDE-4抑制剂(IC(50)<10nM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号